Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-24-020407
Filing Date
2024-06-17
Accepted
2024-06-14 18:16:46
Documents
6
Effectiveness Date
2024-06-17
Reference 429
333-259779

Document Format Files

Seq Description Document Type Size
1 FORM S-8 vtgn20240612_s8.htm S-8 76495
2 EXHIBIT 5.1 ex_687408.htm EX-5.1 6189
3 EXHIBIT 23.1 ex_687406.htm EX-23.1 2493
4 EXHIBIT FILING FEES ex_687405.htm EX-FILING FEES 35115
5 footer.jpg GRAPHIC 9739
6 logo.jpg GRAPHIC 9809
  Complete submission text file 0001437749-24-020407.txt   148725
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: S-8 | Act: 33 | File No.: 333-280246 | Film No.: 241046365
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)